The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Neoadjuvant bevacizumab and anthracycline–taxane-based chemotherapry in 686 triple-negative primary breast cancers: Seconday endpoint analysis of the GeparQuinto study (GBG 44).
B. Gerber
Honoraria - AstraZeneca; GlaxoSmithKline; Novartis; Roche; Sanofi
Research Funding - Novartis
H. Eidtmann
Consultant or Advisory Role - Amgen; Novartis; Roche
M. Rezai
No relevant relationships to disclose
P. A. Fasching
Honoraria - Amgen; Novartis; Pfizer
H. Tesch
Consultant or Advisory Role - GlaxoSmithKline; Novartis; Roche; Sanofi
Honoraria - GlaxoSmithKline; Novartis; Roche; Sanofi
H. Eggemann
No relevant relationships to disclose
I. Schrader
No relevant relationships to disclose
K. Kittel
No relevant relationships to disclose
C. A. Hanusch
No relevant relationships to disclose
R. Kreienberg
Consultant or Advisory Role - AstraZeneca; Novartis
Honoraria - Amgen; Cephalon; GlaxoSmithKline
C. Solbach
No relevant relationships to disclose
C. Jackisch
Consultant or Advisory Role - GlaxoSmithKline; Roche
Honoraria - Amgen; AstraZeneca; GlaxoSmithKline; Roche
G. Kunz
No relevant relationships to disclose
J. U. Blohmer
No relevant relationships to disclose
J. B. Huober
Consultant or Advisory Role - Roche; Sanofi
Honoraria - Sanofi
M. Hauschild
No relevant relationships to disclose
S. Loibl
Consultant or Advisory Role - Roche
Honoraria - Roche
V. Nekljudova
No relevant relationships to disclose
M. Untch
No relevant relationships to disclose
G. Von Minckwitz
Consultant or Advisory Role - Roche; Sanofi
Honoraria - Roche; Sanofi
Research Funding - Roche; Sanofi